STUDY OF ASSOCIATION OF ALOPECIA AND METABOLIC SYNDROME IN YOUNG ME

Not Applicable

Conditions: Health Condition 1: null- Patients of Androgenic Alopecia and Age matched control

Registration Number: CTRI/2020/03/023670

Lead Sponsor: Department of Dermatology Venereology and Leprosy

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Male patient of androgenic alopecia of age group 15 to 35 year will be included in this study.

All patient of grade I to VII (According to Hamilton-Norwood classification).

Patient who will giving written consent to participate in the study.

Exclusion Criteria

Female patient of androgenic alopecia.

Age group <15years or >35 years.

Patient not willing to participate in the study.

Patient not giving consent.

Patient with severe seborrheic dermatitis, alopecia diseases( except AGA) and scalp disorder such as scalp psoriasis and infection.

Patient taking specific drug which can cause alopecia such as corticosteroid, vascular dilators , antihypertensive , anticonvulsant , B-blockers , bronchodilators, diuretics , cimetidine , diazoxide , cyclosporine, ketoconazole ,over the previous 6 months.

Past history of major illness like stroke, cancer, cardiovascular disease, renal disease, Insulin dependent Diabetes Mellitus before 6 months.

Patients having other dermatological disorder which leads to hair loss like SLE, Pemphigus vulgaris.

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Metabolic syndrome criteria <br/ ><br>BP more than 130/85, HDL less than 40,SerumTG morethan150,waist circumference more than 102. <br/ ><br>FBS110,waist circumference102Timepoint: 1year

Secondary Outcome Measures